Summary of Conference Call Records Industry: Swine Industry Key Points 1. **Pig Price Decline**: As of March 20, the average price of live pigs in China has dropped to 9.87 yuan/kg, marking a recent cycle low. This decline has led to significant losses for farmers, with average losses reaching 291.97 yuan per head, approaching the previous cycle's maximum loss of 306.56 yuan per head. The combination of increasing feed costs and a pessimistic outlook has weakened the profitability of fattening pigs, further suppressing the willingness to restock piglets [1][2][3]. 2. **Weak Restocking Season**: The typical post-New Year restocking season for piglets is underperforming, with prices falling to 294 yuan per head, down from 557 yuan per head in the same period last year. The average profit per head has narrowed to 14 yuan, compared to 237 yuan in the previous year. This low demand is expected to lead to accelerated culling of breeding sows, creating a feedback loop that could hasten capacity reduction in the industry [2][3]. 3. **Investment Recommendations**: The report suggests focusing on companies with excess profitability potential amidst a tightening market. Key recommendations include leading breeding companies such as Muyuan Foods and Wens Foodstuffs, as well as other related stocks like Tian Kang Biological and New Hope Liuhe. The report emphasizes the importance of core assets and beta configuration in the current market [3]. Industry: Feed and Animal Health Key Points 1. **Feed Sector Dynamics**: The report highlights the rising prices of fishmeal, with CNF reference prices reaching 2500 USD/ton. Major feed companies like Haida Group are expected to continue raising prices across all feed categories, reflecting their pricing power and profitability amid rising raw material costs. The report recommends Haida Group for its market share and performance potential [3]. 2. **Animal Health Sector**: The report notes the importance of innovation in the animal health sector, particularly in the face of intense competition. The emergence of new products, especially in the pet health market, is expected to drive growth. Companies like Reap Bio and Biokang are highlighted as potential beneficiaries of this trend [3]. Industry: Crop Production Key Points 1. **Grain Security Strategy**: The "14th Five-Year Plan" emphasizes the importance of grain production capacity, aiming for a target of approximately 1.45 trillion jin. The focus is on increasing yields through improved agricultural practices and technology [4][5]. 2. **Seed Industry Focus**: The report stresses the need for advancements in the seed industry to ensure food security, with a push for self-sufficiency in seed sources. Companies like Longping High-Tech and Dabeinong are mentioned as key players in this sector [4][5]. Industry: Poultry Sector Key Points 1. **Chicken Market Dynamics**: The report discusses the impact of avian influenza on breeding stock imports, leading to uncertainty in supply. The price of broiler chicks has increased, while the price of live chickens remains stable. The report suggests that the industry is at a turning point after three years of downturn, with potential for recovery [6][7]. 2. **Egg Market Trends**: The report notes a slight increase in chick and egg prices, with the average price of commercial chicks at 3.56 yuan per chick. The spring restocking season is expected to support prices, with a focus on companies with strong market positions like Xiaoming Co. [7][8]. Industry: Beef Sector Key Points 1. **Beef Price Trends**: The report indicates a rise in prices across the beef supply chain, with prices for fattened bulls at 26.02 yuan/kg, reflecting a year-on-year increase of 7.88%. The dairy sector is still experiencing low prices, with fresh milk prices at 3.02 yuan/kg [8][9]. 2. **Investment Outlook**: The report expresses optimism for the beef sector, particularly as the dairy cow reduction phase nears completion and a super cycle for beef emerges. Companies with strong resources and a "milk-meat linkage" model are expected to perform well [9]. Industry: Pet Market Key Points 1. **Growth of Pet Market**: The pet market is projected to grow significantly, with a forecasted market size of 312.6 billion yuan by 2025. Domestic brands are gaining market share through innovation and localization strategies [10]. 2. **Export Trends**: Pet food exports have seen substantial growth, with a reported increase of 38.57% in quantity and 15.06% in value in early 2026. Companies like Guibao Pet and Zhongchong Co. are highlighted as key players in this expanding market [10].

Core Viewpoint - Yike Food (301116) is focused on establishing a comprehensive support system centered around breeding, which includes six components: breeding, chick supply, feed, animal health, processing, and technology and services, to meet customer needs and ensure stable quality, optimal costs, and food safety in raw material delivery [1] Group 1 - The company aims to reduce intermediate trading links through "chain supplementation and strengthening," thereby enhancing structural efficiency and creating greater value within the industry chain [1]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative price increase of over 20% compared to the benchmark index within the next six months [9]. Core Insights - The company reported a revenue of 559 million yuan for the first half of 2025, representing a year-on-year growth of 15.79%, with a net profit attributable to shareholders of 116 million yuan, up 57.12% year-on-year [4]. - Despite challenges in the pig vaccine segment, significant growth was observed in poultry and pet-related products, with poultry vaccine revenue increasing by 30.01% and pet vaccine revenue rising by 49.65% [5]. - The company has successfully reduced its expense ratio, with total expenses decreasing by 7.97 percentage points year-on-year to 28.89% [5]. - The report projects earnings per share (EPS) of 0.49 yuan, 0.62 yuan, and 0.72 yuan for the years 2025, 2026, and 2027 respectively, reflecting a positive outlook for the company's performance [6]. Company Overview - The latest closing price of the company's stock is 14.63 yuan, with a total market capitalization of 5.1 billion yuan [3]. - The company has a total share capital of 346 million shares, with a debt-to-asset ratio of 15.2% and a price-to-earnings (P/E) ratio of 54.19 [3].

Group 1 - The core point of the news is that Huaying Agriculture (002321) has seen a significant increase in share pledges by its shareholder, Henan Guangzhou Chenyue Industrial Co., Ltd., which pledged 45 million shares, accounting for 2.11% of the total share capital [1] - As of the announcement date, Henan Guangzhou Chenyue Industrial Co., Ltd. has cumulatively pledged 268 million shares, representing 78.36% of its total holdings [1] - The financial performance of Huaying Agriculture for the first half of 2025 shows a decline in revenue and profit, with total revenue of 2.071 billion yuan, down 4.89% year-on-year, and a net profit attributable to shareholders of -20.63 million yuan, down 214.96% year-on-year [3] Group 2 - In Q2 2025, the company reported a single-quarter revenue of 1.302 billion yuan, a decrease of 9.36% year-on-year, and a net profit attributable to shareholders of -8.71 million yuan, down 151.77% year-on-year [3] - The company operates in various sectors including duck breeding, incubation, sale of ducklings, feed production, duck slaughtering and processing, frozen products, cooked food, prepared dishes, and the production and sale of down and down products [4] - The company's debt ratio stands at 64.83%, with investment income of -3.41 million yuan and financial expenses of 30.428 million yuan, resulting in a gross profit margin of 6.81% [3]

Core Insights - Yike Foods (301116) reported a significant decline in revenue and a net loss for the first half of 2025, indicating challenges in the poultry market [1] Financial Performance - The company achieved an operating revenue of 8.747 billion yuan, a year-on-year decrease of 13.1% [1] - The net profit attributable to shareholders was a loss of 181 million yuan, compared to a profit of 117 million yuan in the same period last year [1] Product Pricing and Sales - The decline in revenue was primarily due to lower prices for key products such as poultry meat, poultry seedlings, and down feathers, despite stable sales volume [1] - The decrease in net profit was mainly attributed to reduced gross margins from duck products, ducklings, chicks, and down feathers due to price drops [1]

Group 1 - The core viewpoint of the news is that YuDe Investment has conducted research on a listed company, focusing on its performance and strategic initiatives in the face of market challenges [1] Group 2 - The company, BioShares, is facing challenges such as macroeconomic upgrades and cyclical adjustments in the breeding industry, but it is maintaining revenue growth through innovation and business model optimization [1] - Key products, including foot-and-mouth disease vaccines and circular ring vaccines, have seen significant sales growth, leading to an increase in market share [1] - The company has achieved breakthroughs in vaccine development, including clinical approval for African swine fever subunit vaccines and mRNA vaccines for feline infectious peritonitis, with expectations for market launch between 2027 and 2028 [1]

Group 1 - Companies are transforming their production lines into educational resources, integrating industrial knowledge with hands-on learning experiences [1][2] - SANY Heavy Industry is showcasing its "Lighthouse Factory" in Changsha, allowing students to engage with advanced manufacturing processes and technologies like VR simulations [1][2] - Hunan Hualian Ceramics is creating a unique educational ecosystem by combining traditional craftsmanship with modern design, enabling students to experience and participate in ceramic production [1][2] Group 2 - Hunan Xiangjia Livestock is implementing a full-chain educational approach, demonstrating modern agricultural practices from farm to table, including smart incubation and AI sorting technologies [2][3] - The company reports a significant improvement in hatch rates from 60% to over 95% due to smart incubation systems, and AI sorting can process up to 8 tons of fruit per hour compared to 2,000 pounds manually [3] - The integration of industry and education by these companies serves as a model for fulfilling corporate social responsibility while enhancing educational outcomes, aligning with national policies on industry-education integration [3]

Group 1: Swine Industry - The domestic supply and demand for pigs is expected to improve marginally by Q2 2025, with pig prices supported and entering a phase of gradual upward movement. External factors such as tariff-driven increases in feed raw material prices and higher costs for imported meat are also contributing positively to pig prices. The swine sector is highlighted as a defensive asset amid macroeconomic shocks, reinforcing investment logic. Recommended stocks include Wens Foodstuff Group, Muyuan Foods, and Juxing Agriculture [4][86]. - In 2024, China's pork production is projected to reach 56.75 million tons, accounting for 49% of global production, with consumption at 57.95 million tons, representing 50% of global consumption. This positions China as the world's largest pork producer and consumer [13][15]. - The average price of pork in 2024 is estimated at 16.8 yuan per kilogram, reflecting an increase of 11.8% year-on-year. The swine farming market size is expected to reach 1.5 trillion yuan, up 11.2% year-on-year [17][32]. Group 2: Poultry Industry - The demand for white chicken remains resilient despite uncertainties from U.S.-China tariff policies and avian influenza outbreaks. The consumption of white feather broilers is expected to improve marginally, with recommended stocks including San Nong Development and He Feng Co [5][94]. - In 2024, the total output of meat chickens in China is projected to reach 14.84 billion, with white feather broilers accounting for 60.85% of this figure. The output of white feather broilers is expected to increase by 2.2% year-on-year [99]. Group 3: Animal Health - The market for piglets and poultry chicks is stable, with a solid demand for poultry chicks supported by increasing poultry farming. The market for ruminant and pet vaccines is also expected to remain robust, with recommended stocks including Bio-Group, Kexin Biology, and Pulaike [6]. Group 4: Planting and Seeds - The focus on food security is emphasized, with companies involved in high-yield genetically modified soybeans likely to benefit from the ongoing U.S.-China trade tensions. The third batch of genetically modified corn varieties is expected to be approved for planting, which may increase the area under cultivation [7]. Group 5: Feed Industry - The recovery of the swine sector is expected to boost domestic demand for feed, while overseas markets present new growth opportunities. The demand for pig feed is anticipated to rebound as pig farming profitability improves and pig stocks gradually recover [8]. Group 6: Pet Industry - The upcoming shopping festivals are expected to drive demand for pet food, with domestic brands likely to gain market share due to increased tariffs on imported high-end products. Recommended stocks include Guibao Pet, Zhongchong Co, and Petty Co [6].

Investment Rating - The investment rating for the company is "Add" and maintained [1] Core Views - The company reported a significant decline in revenue and net profit for the year 2024, with total revenue of 1.043 billion yuan, down 16.77% year-on-year, and a net profit of 93 million yuan, down 46.82% year-on-year. However, the first quarter of 2025 showed a recovery with revenue of 279 million yuan, up 18.32% year-on-year, and a net profit of 53 million yuan, up 93.75% year-on-year, driven by growth in poultry vaccines and pharmaceuticals [4][5] - The company is facing pressure in the pig vaccine segment due to increased competition, while the poultry vaccine and pharmaceutical segments are showing growth. The pet vaccine segment is also emerging as a new growth area, with sales exceeding 46 million yuan in 2024 [5] - The company is implementing marketing strategy adjustments and organizational changes to strengthen cost control and core competitiveness, anticipating a recovery in performance as the pig vaccine market stabilizes and new growth opportunities in pet vaccines arise [6] Financial Summary - The company’s financial performance is projected to improve from 2025 to 2027, with expected earnings per share (EPS) of 0.49 yuan, 0.61 yuan, and 0.68 yuan respectively. The revenue is expected to grow from 1.131 billion yuan in 2025 to 1.259 billion yuan in 2027, with net profit projected to increase from 169 million yuan to 237 million yuan over the same period [7][9]

Investment Rating - The investment rating for the company is "Add" and it is maintained [1] Core Views - The company reported a significant decline in revenue and net profit for the year 2024, with total revenue of 1.043 billion yuan, down 16.77% year-on-year, and a net profit of 93 million yuan, down 46.82% year-on-year. However, in Q1 2025, the company showed signs of recovery with a revenue of 279 million yuan, up 18.32% year-on-year, and a net profit of 53 million yuan, up 93.75% year-on-year, driven by growth in poultry vaccines and pharmaceuticals [4][5] - The performance of different vaccine products varies significantly, with poultry vaccines showing continuous growth, while pig vaccines are under pressure due to increased competition in the swine breeding industry. The company’s revenue from poultry vaccines and antibodies increased by 3.31% and 33.80% respectively in 2024 and Q1 2025, while revenue from pig vaccines decreased by 22.58% and 11.64% respectively [5] - The company is expected to recover as it adjusts its marketing strategy and implements organizational changes, with projected EPS for 2025-2027 being 0.49 yuan, 0.61 yuan, and 0.68 yuan respectively, maintaining an "Add" rating [6] Company Overview - The latest closing price of the company's stock is 13.70 yuan, with a total market capitalization of 4.7 billion yuan. The company has a total share capital of 346 million shares, with a debt-to-asset ratio of 15.2% and a P/E ratio of 50.74 [3][4]